Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease

INTRODUCTION: We examine the role of brain apolipoprotein B (apoB) as a putative marker of early tau pathology and cognitive decline. METHODS: Cerebrospinal fluid (CSF) samples from cognitively normal and Alzheimer's disease (AD) participants were collected to measure protein levels of apoB and...

Descripción completa

Detalles Bibliográficos
Autores principales: Picard, Cynthia, Nilsson, Nathalie, Labonté, Anne, Auld, Daniel, Rosa‐Neto, Pedro, Ashton, Nicholas J., Zetterberg, Henrik, Blennow, Kaj, Breitner, John C.B., Villeneuve, Sylvia, Poirier, Judes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293308/
https://www.ncbi.nlm.nih.gov/pubmed/34590423
http://dx.doi.org/10.1002/alz.12442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293308/
https://www.ncbi.nlm.nih.gov/pubmed/34590423
http://dx.doi.org/10.1002/alz.12442

Ejemplares similares